6M8F image
Deposition Date 2018-08-21
Release Date 2019-01-23
Last Version Date 2023-10-11
Entry Detail
PDB ID:
6M8F
Keywords:
Title:
Engineered sperm whale myoglobin-based carbene transferase
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.10 Å
R-Value Free:
0.14
R-Value Work:
0.12
R-Value Observed:
0.12
Space Group:
P 6
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Myoglobin
Gene (Uniprot):MB
Chain IDs:A
Chain Length:154
Number of Molecules:1
Biological Source:Physeter catodon
Peptide-like Molecules
PRD_900003
Primary Citation
Origin of high stereocontrol in olefin cyclopropanation catalyzed by an engineered carbene transferase.
Acs Catalysis 9 1514 1524 (2019)
PMID: 31134138 DOI: 10.1021/acscatal.8b04073

Abstact

Recent advances in metalloprotein engineering have led to the development of a myoglobin-based catalyst, Mb(H64V,V68A), capable of promoting the cyclopropanation of vinylarenes with high efficiency and high diastereo- and enantioselectivity. Whereas many enzymes evolved in nature often exhibit catalytic proficiency and exquisite stereoselectivity, how these features are achieved for a non-natural reaction has remained unclear. In this work, the structural determinants responsible for chiral induction and high stereocontrol in Mb(H64V,V68A)-catalyzed cyclopropanation were investigated via a combination of crystallographic, computational (DFT), and structure-activity analyses. Our results show the importance of steric complementarity and non-covalent interactions involving first-sphere active site residues, heme-carbene, and the olefin substrate, in dictating the stereochemical outcome of the cyclopropanation reaction. High stereocontrol is achieved through two major mechanisms. First, by enforcing a specific conformation of the heme-bound carbene within the active site. Second, by controlling the geometry of attack of the olefin on the carbene via steric occlusion, attractive van der Waals forces and protein-mediated π-π interactions with the olefin substrate. These insights could be leveraged to expand the substrate scope of the myoglobin-based cyclopropanation catalyst toward non-activated olefins and to increase its cyclopropanation activity in the presence of a bulky α-diazo-ester. This work sheds first light into the origin of enzyme-catalyzed enantioselective cyclopropanation, furnishing a mechanistic framework for both understanding the reactivity of current systems and guiding the future development of biological catalysts for this class of synthetically important, abiotic transformations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures